| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| cc-122 | protein cereblon | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Multiple Myeloma[MeSHID:D009101] Liver carcinoma[MeSHID:D006528] Lymphoma[MeSHID:D008223] Diffuse Large B-Cell Lymphoma[MeSHID:D016403] Chronic Lymphocytic Leukemia[MeSHID:D015451] Malignant Neoplasms[MeSHID:D009369] Recurrence (disease attribute)[MeSHID:D012008] Glioblastoma[MeSHID:D005909] |
21.22 | phase 1 | unknown |
| click here to return to the previous page | ||||||||